妇科手术后分层阿片类处方指南的实施效果与患者视角
该研究比较了妇科手术后实施分层阿片类处方指南的620例患者与599例历史对照,发现处方吗啡毫克当量中位数从150降至75(p≤0.001),阿片类再配药率无变化(7.7% vs 6.9%,p=0.62)。在卵巢癌开腹手术患者调查中,尽管处方量减少50%且14.6%出院时未用阿片类,患者疼痛控制满意度仍高(100% vs 92%,p=0.24)。超过75%患者留存剩余阿片类而非丢弃,提示需避免过度处方。
要点
- 分层指南使妇科手术后阿片类处方MME中位数从150降至75,再配药率无增加。
- 卵巢癌开腹手术患者中,处方量减少50%未降低疼痛控制满意度。
- 多数患者留存剩余阿片类药物,强调避免过度处方的必要性。
核心结论
- 采用分层指南减少妇科手术后阿片类处方未增加再配药率或恶化患者对术后疼痛的感知。
- 即使开腹手术,出院后短期内所需阿片类量很少。
- 患者很少丢弃剩余阿片类药物,凸显避免过度处方的需求。
研究设计与样本
- 实施分层阿片类处方指南的前后对照研究,指南组620例,历史对照组599例。
- 对部分卵巢癌开腹手术患者进行问卷调查,评估术后阿片类消耗和患者体验。
主要发现
- 指南实施后95.8%的处方符合指南。
- 处方MME中位数从150降至75(p≤0.001),阿片类再配药率无变化(7.7% vs 6.9%,p=0.62)。
- 调查的卵巢癌患者中,指南组100%和历史对照组92%对疼痛控制满意(p=0.24),尽管处方MME减少50%且14.6%出院时未用阿片类(p=0.002)。
- 出院后消耗MME中位数(IQR)指南组为15(0, 75),历史对照组为24(0, 135);分别有38.2%和42.4%未消耗阿片类。
- 两组术后至停止阿片类使用平均时间均<1周;患者对处方适当性的感知无变化(p=0.49);超过75%患者留存剩余阿片类而非丢弃。
关键数值与推荐
- 分层指南实施后,95.8%的处方符合指南。
- 处方MME中位数从150降至75(p≤0.001)。
- 阿片类再配药率指南组7.7% vs 历史对照组6.9%(p=0.62)。
- 卵巢癌调查中,疼痛控制满意度指南组100% vs 历史对照组92%(p=0.24)。
- 出院时未用阿片类比例指南组14.6%(p=0.002 vs 历史对照组)。
临床怎么用
- 妇科手术后可按分层指南减少阿片类处方量,而不增加再配药或影响疼痛满意度。
- 开腹手术患者出院后阿片类需求低且持续时间短,应避免过量处方。
- 应告知患者剩余阿片类的正确处理方式,减少留存。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVES: To report the impact of implementing standardized guidelines for opioid prescriptions after gynecologic surgery and describe patient perspectives before and after implementation for those undergoing laparotomy for ovarian cancer. METHODS: Patients undergoing gynecologic surgery between October 2017 and May 2018 were prescribed opioids at discharge using tiered guidelines; prescriptions were compared to consecutive historical controls (March 2017-October 2017). A subset of ovarian cancer laparotomy patients were surveyed regarding postoperative opioid consumption and patient experience. RESULTS: A total of 620 women in the tiered guideline cohort were compared with 599 historical controls. Following implementation, 95.8% of prescriptions met guidelines. Median milligram morphine equivalents (MME) prescribed decreased from 150 to 75 (p ≤ 0.001) with no change in opioid refills (7.7 vs 6.9%, p = 0.62). In surveyed ovarian cancer patients, 100% of tiered guideline patients and 92% of historical controls felt satisfied with pain control (p = 0.24), despite a 50% reduction in prescribed MME and 14.6% receiving no opioids at discharge (p = 0.002). The median (IQR) MME consumed after discharge was 15 (0, 75) in tiered guideline patients vs. 24 (0, 135) in historical controls, and 38.2% and 42.4% consumed no opioids, respectively. Mean time between surgery and opioid use cessation was <1 week in both groups; patients' perceptions of opioid prescription appropriateness did not change (p = 0.49). More than 75% of patients kept their remaining opioids rather than dispose of them. CONCLUSIONS: Reducing prescribed opioids after gynecologic surgery using tiered guidelines did not increase opioid refills or worsen patients' perceptions of postoperative pain. Even after laparotomy, very little opioids were required over a short duration after dismissal. Infrequent disposal of leftover opioids highlights the need to avoid over-prescribing.
引用
- Glaser GE, Kalogera E, Kumar A, et al. Outcomes and patient perspectives following implementation of tiered opioid prescription guidelines in gynecologic surgery. Gynecol Oncol. 2020. PMID: 32107048. doi:10.1016/j.ygyno.2020.02.025
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。